CIPLA
Back to Balance Sheet
|
CIPLA Last 5 Year Long Term Provisions History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Long Term Provisions | ₹158 Cr | ₹149 Cr | ₹129 Cr | ₹102 Cr | ₹100 Cr |
What is the latest Long Term Provisions ratio of CIPLA ?
| Year | Long Term Provisions |
|---|---|
| Mar2026 | ₹158 Cr |
| Mar2025 | ₹149 Cr |
| Mar2024 | ₹129 Cr |
| Mar2023 | ₹102 Cr |
| Mar2022 | ₹100 Cr |
How is Long Term Provisions of CIPLA Trending?
| Years | Long Term Provisions | % Change | |
|---|---|---|---|
| Mar2026 | ₹158 Cr | 5.97 | |
| Mar2025 | ₹149 Cr | 15.03 | |
| Mar2024 | ₹129 Cr | 26.53 | |
| Mar2023 | ₹102 Cr | 1.94 | |
| Mar2022 | ₹100 Cr | - | |
Compare Long Term Provisions of peers of CIPLA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| CIPLA | ₹118,984.9 Cr | 4.5% | 1.2% | -1.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹477,312.0 Cr | 0.8% | 6.3% | 18.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹213,879.0 Cr | 8.6% | 20.7% | 18.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹194,094.0 Cr | 1.7% | 9.4% | 38.5% | Stock Analytics | |
| MANKIND PHARMA | ₹102,006.0 Cr | -3.2% | -0.7% | -0.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹95,787.4 Cr | -0.3% | -14.8% | -9.5% | Stock Analytics | |
CIPLA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| CIPLA | 4.5% |
1.2% |
-1.4% |
| SENSEX | 2.7% |
1.5% |
-5.6% |
You may also like the below Video Courses